TMPRSS11D and neoplasm: To understand the status of HATs, levels of which are also reported to change in human tumours [24], we performed a HAT activity assay in normal, early and late stages of tumour serum, but no significant differences were observed, suggesting the H4 hypo-acetylation seen might be due to enhanced HDAC activity in tumour samples compared to normal (Fig. 3d (ii)).